The presentation of dermatoglyphic abnormalities in schizophrenia: A meta-analytic review

Schizophrenia Research

Volumn 142, Issue 1-3, 2012, Pages 1-11

  Golembo Smith, Shana ^a   Walder, Deborah J ^b   Daly, Maureen P ^c   Mittal, Vijay A ^d   Kline, Emily ^e   Reeves, Gloria ^f   Schiffman, Jason ^e  

^a UNIVERSITY OF HAWAII   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Dermatoglyphics; Meta analysis; Neurodevelopment; Schizophrenia

Indexed keywords

ATD ANGLE; CLINICAL FEATURE; CUTANEOUS PARAMETERS; DISEASE ASSOCIATION; FINGER DERMATOGLYPHICS; FINGERTIP ASYMMETRY; FLUCTUATING ASYMMETRY A B RIDGE COUNT; FLUCTUATING ASYMMETRY FINGER RIDGE COUNT; HUMAN; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SKIN DISEASE; SKIN EXAMINATION; TOTAL A B RIDGE COUNT; TOTAL FINGER RIDGE COUNT;

BIOLOGICAL MARKERS; DERMATOGLYPHICS; HAND; HUMANS; SCHIZOPHRENIA;

EID: 84869878296     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.10.002     Document Type: Review

References (133)

1. Arboleda-Flórez J., Ramcharan S., Hreczko T.A., Fick G.H. Dermatoglyphic fluctuating asymmetry as an indicator of genetic predisposition in schizophrenia: preliminary results from a pilot study. New Trends Exp. Clin. Psychiatry 1998, 14(3):125-138.
2. Arrieta I., Martínez B., Criado B., Télez M., Ortega B., Peñagarikano O., Lostao C.M. Dermatoglyphic variation in Spanish Basque populations. Hum. Biol. 2003, 75(2):265-291.
3. Arunpongpaisal S., Nanakorn S., Mongconthawornchai P., Virasiri S., Maneeganondh S., Thepsuthummarat K. Dermatoglyphic traits in Thai schizophrenia patients: a matching case-control study. J. Med. Assoc. Thai. 2011, 94(3):386-394.
4. Avila M.T., Sherr J., Valentine L.E., Blaxton T.A., Thaker G.K. Neurodevelopmental interactions conferring risk for schizophrenia: a study of dermatoglyphic markers in patients and relatives. Schizophr. Bull. 2003, 29(3):595-605.
5. Balgir R.S., Srinivasa Murthy R., Wig N.N. Manic-depressive psychosis and schizophrenia: a dermatoglyphic study. Br. J. Psychiatry 1980, 136:558-561.
6. Barrantes-Vidal N., Fañanás L., Rosa A., Caparrós B., Dolors Riba M., Obiols J.E. Neurocognitive, behavioural and neurodevelopmental correlates of schizotypy clusters in adolescents from the general population. Schizophr. Res. 2003, 61(2-3):293-302.
7. Bax L. MIX 2.0. Professional software for meta-analysis in Excel. Version 2.0.1.4. BiostatXL http://www.meta-analysis-made-easy.com.
8. Becker B.J. The generalizability of empirical research results. Intellectual Talent: Psychological and Social Issues 1996, 363-383. Johns Hopkins University Press, Baltimore. C.P. Benbow, D. Lubinski (Eds.).
9. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50(4):1088-1101.
10. Boin F., Zanardini R., Pioli R., Altamura C.A., Maes M., Gennarelli M. Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol. Psychiatry 2001, 6(1):79-82.
11. Bracha H.S., Torrey E.F., Bigelow L.B., Lohr J.B., Linington B.B. Subtle signs of prenatal maldevelopment of the hand ectoderm in schizophrenia: a preliminary monozygotic twin study. Biol. Psychiatry 1991, 30(7):719-725.
12. Bracha H.S., Torrey E.F., Gottesman I.I., Bigelow L.B., Cunniff C. Second-trimester markers of fetal size in schizophrenia-a study of monozygotic twins. Am. J. Psychiatry 1992, 149(10):1355-1361.
13. Bracha H.S., Lange B., Gill P.S., Gilger J.W., Torrey E.G., Gottesman I.I., et al. Subclinical microcrania, subclinical macrocrania, and fifth-month fetal markers (of growth retardation or edema) in schizophrenia: a co-twin control study of discordant monozygotic twins. Neuropsychiatry Neuropsychol. Behav. Neurol. 1995, 8(1):44-52.
14. Bramon E., Walshe M., McDonald C., Martín B., Toulopoulou T., Wickham H., et al. Dermatoglyphics and schizophrenia: a meta-analysis and investigation of the impact of obstetric complications upon a-b ridge count. Schizophr. Res. 2005, 75(2-3):399-404.
15. Brown A.S., Derkits E.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiatry 2010, 167(3):261-280.
16. Cantor-Graae E., Ismail B., McNeil T.F. Neonatal head circumference and related indices of disturbed fetal development in schizophrenic patients. Schizophr. Res. 1998, 32(3):191-199.
17. Chary T.V.R., Varma S.L., Singh S., Zain A.M., Dharap A.S. Dermatoglyphic patterns in subtypes of schizophrenia. Eur. Psychiatry 1996, 11(1):12-15.
18. Chok J.T., Kwapil T.R. Extralimital triradii as a putative marker of schizotypy. Schizophr. Res. 2005, 76(2-3):239-245.
19. Chok J.T., Kwapil T.R., Scheuermann A. Dermatoglyphic anomalies in psychometrically identified schizotypic young adults. Schizophr. Res. 2005, 72(2-3):205-214.
20. Cicchetti D., Rogosch F.A. Equifinality and multifinality in developmental psychopathology. Dev. Psychopathol. 1996, 8(4):597-600.
21. Cochran W.G. The combination of estimates from different experiments. Biometrics 1954, 10(1):101-129.
22. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Lawrence Erlbaum Associates, Hillsdale. second ed.
23. Cohen J. A power primer. Psychol. Bull. 1992, 112(1):155-159.
24. Cohen-Bendahan C.C.C., van de Beek C., Berenbaum S.A. Prenatal sex hormone effects on child and adult sex-typed behavior: methods and findings. Neurosci. Biobehav. Rev. 2005, 29(2):353-384.
25. Compton M.T., Walker E.F. Physical manifestations of neurodevelopmental disruption: are minor physical anomalies part of the syndrome of schizophrenia?. Schizophr. Bull. 2009, 35(2):425-436.
26. Compton M.T., Bollini A.M., McKenzie M.L., Kryda A.D., Rutland J., Weiss P.S., et al. Neurological soft signs and minor physical anomalies in patients with schizophrenia and related disorders, their first-degree biological relatives, and non-psychiatric controls. Schizophr. Res. 2007, 94(1-3):64-73.
27. Cummins H., Midlo C. Finger Prints, Palms and Soles: An Introduction to Dermatoglyphics 1961, Dover Publications, New York.
28. Dalman C., Allebeck P., Cullberg J., Grunewald C., Köster M. Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort. Arch. Gen. Psychiatry 1999, 56(3):234-240.
29. Daly M.P., Gooding D.C., Jessen H.M., Auger A.P. Indicators of developmental deviance in individuals at risk for schizophrenia. Schizophr. Res. 2008, 101(1-3):152-160.
30. Davis J.O., Bracha H.S. Prenatal growth markers in schizophrenia: a monozygotic co- twin control study. Am. J. Psychiatry 1996, 153(9):1166-1172.
31. Delisi L.E. Is there a viral or immune dysfunction etiology to schizophrenia? Reevaluation a decade later. Schizophr. Res. 1996, 22(1):1-4.
32. Dvořáková M., Zvolský P. Dermatoglyphs in endogenous psychoses: II. Female palm prints. Cesk. Psychiatr. 1979, 75(1):6-15.
33. Elizarrarás-Rivas J., Fragoso-Herrera R., Cerdán-Sánchez L.F., Ramos-Zepeda R., Totsuka-Sutto S.E., Gallegos-Arreola P., et al. Dermatoglyphics and schizophrenia: a Mexican study. Aust. N. Z. J. Psychiatry 2002, 36(5):704-705.
34. Ellman L.M., Cannon T.D. Environmental pre- and peri-natal influence in etiology. Clinical Handbook of Schizophrenia 2008, 65-73. K.T. Mueser, D.V. Jeste (Eds.).
35. Engel S.A.M., Erichsen H.C., Savitz D.A., Thorp J., Chanock S.J., Olshan A.F. Risk of spontaneous preterm birth is associated with common proinflammatory cytokine polymorphisms. Epidemiology 2005, 16(4):469-477.
36. Fañanás L., Moral P., Bertranpetit J. Quantitative dermatoglyphics in schizophrenia- study of family history subgroups. Hum. Biol. 1990, 62(3):421-427.
37. Fañanás L., van Os J., Hoyos C., McGrath J., Mellor C.S., Murray R. Dermatoglyphic a-b ridge count as a possible marker for developmental disturbance in schizophrenia: replication in two samples. Schizophr. Res. 1996, 20(3):307-314.
38. Fañanás L., Gutiérrez B., Bosch S., Carandell F., Obiols J.E. Presence of dermatoglyphic ridge dissociation in a schizotypy-affected subject in a pair of discordant twins. Schizophr. Res. 1996, 21(2):125-127.
39. Fatjó-Vilas, Gourion D., Campanera S., Mouaffak F., Levy-Rueff M., Navarro M.E., et al. New evidence of gene and environment interactions affecting prenatal neurodevelopment in schizophrenia-spectrum disorders: a family dermatoglyphic study. Schizophr. Res. 2008, 103(1-3):209-217.
40. Fearon P., Lane A., Airie M., Scannell J., McGowan A., Byrne M., et al. Is reduced dermatoglyphic a-b ridge count a reliable marker of developmental impairment in schizophrenia?. Schizophr. Res. 2001, 50(3):151-157.
41. Field A. The problems in using fixed-effects models of meta-analysis on real-world data. Underst. Stat. 2003, 2(2):105-124.
42. Gabalda M.K., Compton M.T. Dermatoglyphic indices and minor physical anomalies in patients with schizophrenia and related disorders, their first-degree biological relatives, and non psychiatric controls. Psychiatry Res. 2010, 178(2):255-259.
43. Gay, O., Plaze, M., Oppenheim, C., Mouchet-Mages, S., Gaillard, R., Olié, J.P., Krebs, M.O., Cachia, A., in press. Cortex morphology in first-episode psychosis patients with neurological soft signs. Schizophr. Bull. Advance Access published August 13, 2012.
44. Golembo S., Schiffman J., Kline E., Sorensen H., Mortensen E., Stapleton L., et al. Premorbid multivariate markers of neurodevelopmental instability in the prediction of adult schizophrenia-spectrum disorder: a high-risk prospective investigation. Schizophr. Res. 2012, 139(1-3):129-135.
45. Green M.F., Bracha H.S., Satz P., Christenson C.D. Preliminary evidence for an association between minor physical anomalies and second trimester neurodevelopment in schizophrenia. Psychiatry Res. 1994, 53(2):119-127.
46. Haukvik U.K., Saetre P., McNeil T., Bjerkan P.S., Andreassen O.A., Werge T., Jönsson E.G., Agartz I. An exploratory model for G×E interaction on hippocampal volume in schizophrenia; obstetric complications and hypoxia-related genes. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34(7):1259-1265.
47. Hilbun W.B. Dermatoglyphic findings on a group of psychotic children. J. Nerv. Ment. Dis. 1970, 151(5):352-358.
48. Holt S.B. The Genetics of Dermal Ridges 1968, Thomas, Springfield IL.
49. Hunter J.E., Schmidt F.L. Fixed effects vs. random effects meta-analysis models: implications for cumulative knowledge in psychology. Int. J. Sel. Assess. 2000, 8:275-292.
50. Jantz R.L. Anthropological dermatoglyphic research. Annu. Rev. Anthropol. 1987, 16:161-177.
51. Jelovac N., Miličić J., Rudan P., Milas M. Dermatoglyphic analysis in borderline personality disorder. Psychiatr. Danub. 1995, 7(3-4):139-145.
52. Jelovac N., Miličić J., Milas M., Dodig G., Turek S., Ugrenović Ž. Dermatoglyphic analysis in bipolar affective disorder and schizophrenia-"Continuum of Psychosis" hypothesis corroborated?. Coll. Antropol. 1999, 23(2):589-595.
53. Jhingan H.P., Munjal G.C. Dermatoglyphics in female catatonic schizophrenics. Indian J. Psychiatry 1989, 31(4):329-332.
54. Jhingan H.P., Munjal G.C. Dermatoglyphics in male catatonic schizophrenics. Indian J. Psychiatry 1990, 32(2):188-192.
55. Johnstone E.C., Ebmeier K.P., Miller P., Owens D.G.C., Lawrie S.M. Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br. J. Psychiatry 2005, 186:18-25.
56. Karlsgodt K.H., Sun D., Cannon T.D. Structural and functional brain abnormalities in schizophrenia. Curr. Dir. Psychol. Sci. 2010, 19(4):226-231.
57. Karmakar B., Yakovenko K., Kobyliansky E. Complex segregation analysis of quantitative dermatoglyphic traits in five Indian populations. Ann. Hum. Biol. 2005, 32(4):445-468.
58. Karmarkar B., Kobyliansky E. Sexual dimorphism in two types of dermatoglyphic traits in the Turkmenian population of Russia: principal component analysis. Anthropol. Anz. 2009, 67:253-268.
59. Katila H., Hänninen K., Hurme M. Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol. Psychiatry 1999, 4(2):179-181.
60. Kelly B.D., Cotter D., Denihan C., Larkin D., Murphy P., Kinsella A. Neurological soft signs and dermatoglyphic anomalies in twins with schizophrenia. Eur. Psychiatry 2004, 19(3):159-163.
61. Kemali D.K., Polani P.E., Polani N., Amati A. Dermatoglyphics in a small sample of Italian males, mostly with paranoid schizophrenia. Acta Neurol. 1972, 27(5):506-521.
62. Kemali D., Polani N., Polani P.E., Amati A. A dermatoglyphic study of 219 Italian schizophrenic males. Clin. Genet. 1976, 9(1):51-60.
63. Khashan A.S., Abel K.M., McNamee R., Pedersen M.G., Webb R.T., Baker P.N., et al. Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events. Arch. Gen. Psychiatry 2008, 65(2):146-152.
64. King S., Mancini-Marïe A., Brunet A., Walker E., Meaney M.J., Laplante D.P. Prenatal maternal stress from a natural disaster predicts dermatoglyphic asymmetry in humans. Dev. Psychopathol. 2009, 21(2):343-353.
65. Kobyliansky E., Micle S. Dermatoglyphic sexual dimorphism in North African Jews. Int. J. Anthropol. 1988, 3:77-91.
66. Langsley N., Miller P., Lawrie S.M., McIntosh A., Johstone E.C., Byrne M. Dermatoglyphics and schizophrenia: findings from the Edinburgh high risk study. Schizophr. Res. 2005, 74(1):122-124.
67. Lewis S.W., Murray R.M. Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia. J. Psychiatr. Res. 1987, 21(4):413-421.
68. Lobato M.I., Belmonte-de-Abreu P., Kninjik D., Teruchkin B., Ghisolfi E., Henriques A. Neurodevelopmental risk factors in schizophrenia. Braz. J. Med. Biol. Res. 2001, 34(2):155-163.
69. Markow T.A., Gottesman I.I. Fluctuating dermatoglyphic asymmetry in psychotic twins. Psychiatry Res. 1989, 29(1):37-43.
70. Markow T.A., Wandler K. Fluctuating dermatoglyphic asymmetry and the genetics of liability to schizophrenia. Psychiatry Res. 1986, 19(4):323-328.
71. Martín B., Fañanás L., Gutierrez B., Chow E.W., Bassett A.S. Dermatoglyphic profile in 22q deletion syndrome. Am. J. Med. Genet. B Neuropsychiatr. 2004, 128B(1):46-49.
72. McNeil T.F., Cantor-Graae E. Obstetric complications as risk factors for schizophrenia. Int. J. Ment. Health 2000, 29(4):73-83.
73. Mellor C.S. Dermatoglyphics in schizophrenia: I. Qualitative aspects. Br. J. Psychiatry 1968, 114(516):1387-1397.
74. Mellor C.S. Dermatoglyphic evidence of fluctuating asymmetry in schizophrenia. Br. J. Psychiatry 1992, 160:467-472.
75. Micle S., Kobyliansky E. Dermatoglyphic sexual dimorphism in Israelis: principal components and discriminant analyses applied to quantitative traits. Hum. Biol. 1986, 58(4):485-498.
76. Micle S., Kobyliansky E. Asymmetry and diversity of dermatoglyphics: pattern types and ridge counts. Hum. Biol. 1991, 60:123-134.
77. Mittal V.A., Walker E.F. Minor physical anomalies and vulnerability in prodromal youth. Schizophr. Res. 2011, 129(2-3):116-121.
78. Mittal V.A., Sacazawa M., Walder D.J., Willhite R., Walker E.F. Prenatal exposure to viral infection and conversion among adolescents at high-risk for psychotic disorders. Schizophr. Res. 2008, 99(1-3):375-376.
79. Mittal V.A., Ellman L.M., Cannon T.D. Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications. Schizophr. Bull. 2008, 34(6):1083-1094.
80. Müller N., Riedel M., Gruber R., Ackenheil M., Schwarz M.J. The immune system and schizophrenia: an integrative view. Neuroimmunomodulation: Perspectives at the New Millennium 2000, 456-467. Annals of the New York Academy of Sciences, New York. A. Conti, G.J.M. Maestroni, S.M. McCann, E.M. Sternberg, J.M. Lipton, C.C. Smith (Eds.).
81. Náměstek S., Hronek J. Dermatoglyphs in hospitalized schizophrenic patients and their importance in the genesis of schizophrenia. Cesk. Psychiatr. 1974, 70(5):284-290.
82. Newell-Morris L.L., Fahrenbruch C.E., Sackett G.P. Prenatal psychological stress, dermatoglyphic asymmetry and pregnancy outcome in the pigtailed macaque (Macaca nemestina). Biol. Neonate 1989, 56(2):61-75.
83. Niznikiewicz M.A., Kubicki M., Shenton M.E. Recent structural and functional imaging findings in schizophrenia. Curr. Opin. Psychiatry 2003, 16(2):123-147.
84. Páez F., Apiquian R., Fresán A., Puig A., Orozco B., De la Fuente J., et al. Dermatoglyphic study of positive and negative symptoms in schizophrenia. Salud Ment. 2001, 24(1):28-32.
85. Palmer A.R. Fluctuating asymmetry analyses: a primer. Developmental Instability: Its Origins and Evolutionary Implications 1994, 335-364. Kluwer, Dordrecht, Netherlands. T.A. Markow (Ed.).
86. Palmer A.R., Strobeck C. Fluctuating asymmetry: measurement, analysis, patterns. Annu. Rev. Ecol. Syst. 1986, 17:391-421.
87. Perkovic T. Determination of schizophrenic biological traits: study of digito-palmar dermatoglyphs. Soc. Psihijatr. 1977, 5(3):271-320.
88. Polednak A.P. Dermatoglyphics of Negro schizophrenia males. Br. J. Psychiatry 1972, 120397-120398.
89. Ponnudurai R. Relevance of sequential development of dermatoglyphics to schizophrenia. Psychiatry Res. 1999, 89(1):59-67.
90. Qiu A., Tuan T.A., Woon P.S., Abdul-Rahman M.F., Graham S., Sim K. Hippocampal-cortical structural connectivity disruptions in schizophrenia: an integrated perspective from hippocampal shape, cortical thickness, and integrity of white matter bundles. Neuroimage 2010, 52(4):1181-1189.
91. Reed T. Dermatoglyphics in medicine-problems and use in suspected chromosome abnormalities. Am. J. Med. Genet. 1981, 8(4):411-429.
92. Reilly J.L., Murphy P.T., Byrne M., Larkin C., Gill M., O'Callaghan E., et al. Dermatoglyphic fluctuating asymmetry and atypical handedness in schizophrenia. Schizophr. Res. 2001, 50(3):159-168.
93. Rosa A., Fañanás L., Bracha H.S., Torrey E.F., van Os J. Congenital dermatoglyphic malformations and psychosis: a twin study. Am. J. Psychiatry 2000, 157(9):1511-1513.
94. Rosa A., Fañanás L., Marcelis M., van Os J. A-b ridge count and schizophrenia. Schizophr. Res. 2000, 46(2-3):285-286.
95. Rosa A., Fañanás L., van Os J., Ribchester T., Davies N., Arias B., et al. Further evidence that congenital dermatoglyphic abnormalities are associated with psychosis: a twin study. Schizophr. Bull. 2002, 28(4):697-701.
96. Rosa A., Marcelis M., Suckling J., Hofman P., Bullmore E., Delespaul P., et al. Nonreplication of the association between ab-ridge count and cerebral structural measures in schizophrenia. Compr. Psychiatry 2003, 44(6):459-461.
97. Rosa A., Cuesta M.J., Peralta V., Zarzuela A., Serrano F., Martínez-Larrea A., et al. Dermatoglyphic anomalies and neurocognitive deficits in sibling pairs discordant for schizophrenia spectrum disorders. Psychiatry Res. 2005, 137(3):215-221.
98. Rose R.J. Asymmetry of a-b ridge count and behavioral discordance of monozygotic twins. Behav. Genet. 1987, 17(2):125-140.
99. Rosenthal R. The 'file drawer' problem and tolerance for null results. Psychol. Bull. 1979, 86(3):638-641.
100. Rosner F., Steinberg F.S. Dermatoglyphic patterns of Negro men with schizophrenia. Dis. Nerv. Syst. 1968, 29(11):739-743.
101. Rothhammer F., Pereira G., Camousseight A., Benado M. Dermatoglyphics in schizophrenic patients. Hum. Hered. 1971, 21(2):198-202.
102. Saha S., Loesch D., Chant D., Welham J., El-Saadi O., Fañanás L., et al. Directional and fluctuating asymmetry in finger and a-b ridge counts in psychosis: a case-control study. BMC Psychiatry 2003, 3. (ArtID 3).
103. Sank D. Dermatoglyphics of childhood schizophrenia. Acta Genet. Stat. Med. 1968, 18(4):300-314.
104. Schiffman J., Ekstrom M., LaBrie J., Schulsinger F., Sorensen H., Mednick S. Minor physical anomalies and schizophrenia-spectrum disorders: a prospective investigation. Am. J. Psychiatry 2002, 159(2):238-243.
105. Schiffman J., Walker E., Ekstrom M., Schulsinger F., Sorensen H., Mednick S. Childhood videotaped social and neuromotor precursors of schizophrenia: a prospective investigation. Am. J. Psychiatry 2004, 161(11):2021-2027.
106. Shakibaei F., Asadollahi G.A., Amirpooyan T. Dermatoglyphics in patients with schizophrenia. J. Res. Med. Sci. 2011, 16:1055-1061.
107. Shepherd A.M., Laurens K.R., Matheson S.L., Carr V.J., Green M.J. Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci. Biobehav. Rev. 2012, 36(4):1342-1356.
108. Sivkov S.T., Akavaliev V. Dermatoglyphics in schizophrenia: Qualitative aspects. Folia Med. 1998, 40(3):44-50.
109. Sivkov S.T., Akavaliev V., Akabaliev K.V. Fluctuating asymmetry in dermatoglyphic traits in schizophrenic patients. Folia Med. 2007, 49(1-2):5-10.
110. Srinivasa Murthy R., Wig N.N. Dermatoglyphics in schizophrenia: the relevance of positive family history. Br. J. Psychiatry 1977, 130:56-58.
111. Stowens D., Sammon J.W., Proctor A. Dermatoglyphics in female schizophrenia. Psychiatr. Q. 1970, 44(1):516-532.
112. Tényi T., Csábi G., Szabó R., Trixler M. Informative morphogenetic variants in schizophrenia and in bipolar affective disorder. Psychiatr. Hung. 2000, 15(2):163-169.
113. Turek S. Dermatoglyphics and schizophrenia-analysis of quantitative traits. Coll. Antropol. 1990, 14:137-150.
114. Van Erp T.G., Saleh P.A., Rosso I.M., Huttunen M., Lonnqvist J., Pirkola T., Salonen O., Valanne L., Poutanen V.P., Standertskjold-Nordenstam C.G., Cannon T.D. Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am. J. Psychiatry 2002, 159(9):1514-1520.
115. van Oel C.J., Baare W.F.C., Pol H.E.H., Haag J., Balazs J., Dingemans A., Kahn R.S., Sitskoorn M.M. Differentiating between low and high susceptibility to schizophrenia in twins: the significance of dermatoglyphic indices in relation to other determinants of brain development. Schizophr. Res. 2001, 52(3):181-193.
116. Van Os J., Fañanás L., Cannon M., Macdonald A., Murray R. Dermatoglyphic abnormalities in psychosis: a twin study. Biol. Psychiatry 1997, 41(5):624-626.
117. van Os J., Woodruff P.W.R., Fañanas L., Ahmad F., Shuriquie N., Howard R., Murray R.M. Association between cerebral structural abnormalities and dermatoglyphic ridge counts in schizophrenia. Compr. Psychiatry 2000, 41(5):380-384.
118. van Valen L.A. A study of fluctuating asymmetry. Evolution 1962, 16:125-142.
119. Varma S.L., Chary T.V.R., Singh S., Azhar M.Z., Dharap A.S. Dermatoglyphic patternsin schizophrenia patients. Acta Psychiatr. Scand. 1995, 91:213-215.
120. Walder D.J., Mittal V., Trotman H.D., McMillan A.L., Walker E.F. Neurocognition and conversion to psychosis in adolescents at high-risk. Schizophr. Res. 2008, 101(1-3):161-168.
121. Walder, D.J., Ospina, L., Daly, M.P., Statucka, M., Raparia, E., in press. Early neurodevelopment and psychosis risk: Role of neurohormones and biological sex in modulating genetic, prenatal and sensory processing factors in brain development, in: Anastassiou-Hadjicharalambous, X. (Ed.), Psychosis: Causes, Diagnosis and Treatment. Nova Science.
122. Walder D.J., Statucka M., Daly M.P., Axen K., Haber M. Biological sex and mentrual cycle phase modulation of cortisol levels and psychiatric symptoms in a non-clinical sample of young adults. Psychiatry Res. 2012, 197(3):314-321.
123. Walker E.F., Diforio D. Schizophrenia: a neural diathesis-stress model. Psychol. Rev. 1997, 104(4):667-685.
124. Walker E.F., Walder D.J. Neurohormonal aspects of the development of psychotic disorders. Neurodevelopmental Mechanisms in Psychopathology 2002, Cambridge University Press, Boston. D. Cichetti, E. Walker (Eds.).
125. Walker E.F., Savoie T., Davis D. Neuromotor precursors of schizophrenia. Schizophr. Bull. 1994, 20(3):441-451.
126. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320(5875):539-543.
127. Weinberg S.M., Jenkins E.A., Marazita M.L., Maher B.S. Minor physical anomalies in schizophrenia: a meta-analysis. Schizophr. Res. 2007, 89(1-3):72-85.
128. Weinberger D.R. Implications for normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 1987, 44:660-669.
129. Weinberger D.R. Schizophrenia as a neurodevelopmental disorder: a review of the concept. Schizophrenia 1995, Blackwood, London. S.R. Hirsch, D.R. Weinberger (Eds.).
130. Weinstein D.D., Diforio D., Schiffman J., Walker E., Bonsall R. Minor physical anomalies, dermatoglyphic asymmetries, and cortisol levels in adolescents with schizotypal personality disorder. Am. J. Psychiatry 1999, 156(4):617-623.
131. Yousefi-Nooraie R., Mortaz-Hedjri S. Dermatoglyphic asymmetry and hair whorl patterns in schizophrenic and bipolar patients. Psychiatry Res. 2008, 157(1-3):247-250.
132. Zavala C., Núñez C. Dermatoglyphics in schizophrenia. J. Hum. Genet. 1970, 18(4):407-420.
133. Zhang H.-G., Chen Y.-F., Ding M., Jin L., Case D.T., Jiao Y.P., et al. Dermatoglyphics from all Chinese ethnic groups reveal geographic patterning. PLoS One 2010, 5:e8783.